Hair growth stimulators
    1.
    发明申请
    Hair growth stimulators 审中-公开
    头发生长刺激剂

    公开(公告)号:US20060025448A1

    公开(公告)日:2006-02-02

    申请号:US11185919

    申请日:2005-07-20

    IPC分类号: A61K31/454 A61K31/4152

    CPC分类号: A61K31/415 C07D409/04

    摘要: The present invention discloses method for modulating the growth of body and/or head/cranial hair on mammalian organisms, for example humans, by administering thereto, whether topically and/or systemically, therapeutically effective amounts of at least one cannabinoid ligands, in combination with or without other suitable therapeutically active agents.

    摘要翻译: 本发明公开了通过对哺乳动物生物体(例如人)的身体和/或头/头发的生长进行调节,无论是局部地和/或全身地治疗有效量的至少一种大麻素配体,结合 或没有其他合适的治疗活性剂。

    Tricyclic Pyrazole Derivatives as Cannabinoid Receptor Modulators
    4.
    发明申请
    Tricyclic Pyrazole Derivatives as Cannabinoid Receptor Modulators 失效
    三环吡唑衍生物作为大麻素受体调节剂

    公开(公告)号:US20080051386A1

    公开(公告)日:2008-02-28

    申请号:US11632236

    申请日:2005-07-08

    CPC分类号: C07D495/14 C07D495/04

    摘要: The present invention relates to novel compounds of general formula (I), their regioisomers, tautomeric forms, novel intermediates involved in their synthesis. The present invention also relates to a process of preparing compounds of general formula (I), their regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.

    摘要翻译: 本发明涉及通式(I)的新型化合物,其区域异构体,互变异构体,涉及其合成的新型中间体。 本发明还涉及制备通式(I)的化合物,其区域异构体,其互变异构形式,其药学上可接受的盐,含有它们的药物组合物以及参与其合成的新中间体的方法。

    Tricyclic pyrazole derivatives as cannabinoid receptor modulators
    6.
    发明授权
    Tricyclic pyrazole derivatives as cannabinoid receptor modulators 失效
    三环吡唑衍生物作为大麻素受体调节剂

    公开(公告)号:US08030345B2

    公开(公告)日:2011-10-04

    申请号:US11632236

    申请日:2005-07-08

    IPC分类号: A61K31/38 C07D495/02

    CPC分类号: C07D495/14 C07D495/04

    摘要: The present invention relates to novel compounds of general formula (I), their regioisomers, tautomeric forms, novel intermediates involved in their synthesis. The present invention also relates to a process of preparing compounds of general formula (I), their regioisomers, their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.

    摘要翻译: 本发明涉及通式(I)的新型化合物,其区域异构体,互变异构体,涉及其合成的新型中间体。 本发明还涉及制备通式(I)的化合物,其区域异构体,其互变异构形式,其药学上可接受的盐,含有它们的药物组合物以及参与其合成的新中间体的方法。